Milestone Pharmaceuticals is trading 6.2% up today at $1.19 as the stock moves in line with a broad-market rally and improved investor risk appetite.
- Major U.S. indices are all gaining more than 1.5%, supported by easing geopolitical tensions and lower energy prices.
- Solid economic data is further boosting market sentiment, with the stock's movement appearing to follow broader trends rather than company-specific news.